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Protozoan parasites such as Plasmodium spp., Leishmania spp., Trypanosoma spp., 
and Toxoplasma gondii are major causes of parasitic diseases in both humans and 
animals. The immune system plays a critical role against protozoa, but their immune 
mechanism remains poorly understood. This highlights the need to investigate the 
function of immune cells involved in the process of parasite infections and the responses 
of host immune system to parasite infections. Mast cells (MCs) are known to be central 
players in allergy and anaphylaxis, and it has been demonstrated that MCs have crucial 
roles in host defense against a number of different pathogens, including parasites. To 
date, there are many studies that have examined the interaction of helminth-derived anti-
gens and MCs. As one of the major effector cells, MCs also play an important role in the 
immune response against some parasitic protozoa, but their role in protozoan infections 
is, however, less well characterized. Herein, we review the current knowledge about the 
roles of MCs and their mediators during infections involving highly pathogenic protozoa 
including Plasmodium spp., Leishmania spp., Trypanosoma spp., and T. gondii. We 
offer a general review of the data from patients and experimental animal models infected 
with the aforementioned protozoa, which correlate MCs and MC-derived mediators with 
exacerbated inflammation and disease progression as well as protection against the 
parasitic infections in different circumstances. This review updates our current under-
standing of the roles of MCs during parasitic protozoan infections, and the participation 
of MCs in parasitic protozoan infections could be of a potential therapeutic target.
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inTRODUCTiOn
Plasmodium spp., Leishmania spp., Trypanosoma spp., and Toxoplasma gondii are some of the 
most important medical protozoan parasites that cause diseases in humans. Plasmodium spp. is a 
group of mosquito-borne parasitic protozoa. After being bitten by an Anopheles mosquito, sporo-
zoites penetrate the liver cells of the host and produce thousands of free merozoites, which invade 
erythrocytes and then burst the cells to release the merozoites to invade other erythrocytes and 
cause clinical symptoms (1). Leishmania spp. comprises several species and causes leishmaniasis, 
which affects more than 300 million people worldwide (2). This parasite has a complex life cycle 
composed of two distinct stages: the promastigote form found in the female sandfly vector and the 
amastigote form replicated in the mammalian host (3). Trypanosoma brucei causes the fatal illness 
human African trypanosomiasis (4), which is adapted to parasitize the mammalian bloodstream 
2Lu and Huang The Roles of MCs in Parasitic Protozoan Infections
Frontiers in Immunology | www.frontiersin.org April 2017 | Volume 8 | Article 363
after inoculation by the tsetse fly (Glossina spp.). Trypanosoma 
cruzi causes American trypanosomiasis or Chagas disease. This 
parasite chronically infects millions of people, and up to 30% of 
the infected individuals ultimately develop chronic cardiomyo-
pathy or gastrointestinal disease. Transmission of this parasite 
occurs when trypomastigotes in vector (triatomine bug) feces 
enter bite wounds, mucous membranes of the nose, oral cavity, 
or conjunctiva of the new host. In addition, transmission can also 
occur through an oral route by ingestion of food contaminated 
with triatomine bugs or their feces (5, 6). T. gondii is spreading 
all over the world, which can infect a vast number of intermedi-
ate hosts and causes toxoplasmosis in both humans and animals 
(7). Toxoplasmic encephalitis is a subsequent risk for all severely 
immunocompromised patients (8). Moreover, infection during 
pregnancy may cause serious lesions to the fetus through con-
genital infection (9).
Mast cells (MCs) are tissue-resident, granule-containing 
cells, which participate in the regulation of innate and adap-
tive immune responses (10). In healthy individuals, MCs are 
involved in tissue homeostasis, tissue repair, and host defense 
via the release of different kind of pro-inflammatory mediators, 
proteases, and cytokines (11). Degranulation of MCs is essential 
for host defense against parasitic infections (12). It is well known 
that MCs play an important role in parasitic helminth infections 
(13). Accumulating evidences have demonstrated that MCs have 
pivotal roles in parasitic protozoan diseases (14, 15); this has led 
us to focus on the role of MCs in the immune responses against 
parasitic infections including Plasmodium spp., Leishmania spp., 
Trypanosoma spp., and T. gondii. The main function of MCs in the 
aforementioned protozoa is summarized in Table 1.
MCs in Plasmodium spp. inFeCTiOn
MCs in the Skin of Patients and Animals 
with Plasmodium infection
Mast cells are abundant in tissues exposed to the external envi-
ronment, including the skin (45). Malaria parasites may promote 
malaria pathogenesis by triggering MCs. Plasmodium berghei-
infected Anopheles gambiae mosquito saliva can trigger mouse 
dermal MC degranulation as little as 5 min after the mosquito 
bite. One hour after the bite, MCs were observed in the vicinity 
of sporozoites on skin sections from mice bitten by P. berghei-
infected An. gambiae mosquitoes (17). Saliva-induced activation 
of dermal MCs causes lymph node swelling via the recruitment of 
T cells, B cells, dendritic cells (DC), and monocytes/macrophages 
(Mφ) as well as neutrophils (46, 47). Importantly, it was shown 
that there was an increase in MC activation and degranulation 
in the skin dermis of severe Plasmodium falciparum malaria 
patients, compared to controls. The percentage of MC degranu-
lation was significantly correlated with parasitemia and disease 
severity, which are relevant to MC mediators (16).
MCs in Cerebral Malaria (CM)
Mast cells are found in the central nervous system, especially along 
the blood vessels and leptomeninges (48). Kenyan children with 
mild and severe malaria were shown to have increased plasma 
levels of Flt3 ligand (Flt3L) (15). Elevated serum Flt3L levels and 
DC expansion were found in patients infected by P. falciparum 
and mice with Plasmodium infection. MCs are an important 
source of Flt3L, a soluble cytokine that influences DC function, 
with the subsequent activation of pathogenic CD8+ T  cells, a 
critical effector of the disease (49). After infection with P. berghei 
ANKA, compared to MC-deficient WBB6F1-W/Wv mice, the con-
trol littermate WBB6F1+/+ C57BL/6 mice had lower parasitemia 
and mortality with higher tumor necrosis factor (TNF) levels. 
Malarial antigens from P. berghei ANKA are able to stimulate Mφ 
and MCs to secrete TNF in vitro. An in vivo study further dem-
onstrated that MCs are a critical source of TNF in addition to Mφ 
and T cells in murine malaria. Therefore, MCs and MC-derived 
TNF play an important role in protection against experimental 
cerebral malaria (ECM) (18). Furthermore, P. berghei ANKA 
peroxiredoxin induces a significant amount of MC-derived TNF 
secretion from IgE-mediated protection through FcεRI on MCs 
and innate immunity by means of toll-like receptor (TLR) 4 with 
myeloid differentiation primary response gene 88 and MD-2 and 
plays a role in innate and acquired immune responses in malaria 
(50). Conversely, one study reported that malaria developed in 
MC-deficient and basophil-depleted C57BL/6 mice infected with 
P. berghei ANKA was similar to that developed in wild-type mice, 
suggesting that MCs and basophils were not involved in malaria 
pathogenesis in this model (19).
Histamine has four different receptors, namely H1R, H2R, 
H3R, and H4R, which mediate numerous different effects (51). 
Histamine is the major MC mediator in malaria, and its signal-
ing has been associated with the severity of P. falciparum malaria 
(21). In addition, the significant elevation of the blood concentra-
tions of IgE and IgE-antimalarial antibodies has also been linked 
to the disease severity in falciparum malaria patients (52). As a 
DC modulator, especially during early phases of the immune 
response, histamine causes increased vascular permeability and 
subsequent extensive vascular damage to endothelial cells dur-
ing malaria infection (47). Experiments have demonstrated that 
histamine binding to H1R and H2R increases the susceptibility of 
infection with P. berghei in H1R−/− and H2R−/− mice (21). H3R−/− 
mice infected with P. berghei ANKA have an accelerated onset of 
CM and mortality, accompanied by an earlier loss of blood–brain 
barrier integrity, earlier formation of hemorrhagic lesions, higher 
sequestration of CD4+ and CD8+ T cells in the brain, and higher 
serum histamine levels compared to C57BL/6 wild-type mice. 
The severity of CM is related to the increased plasmatic levels of 
histamine in H3R−/− mice during the infection (20). Mice geneti-
cally deficient in the histidine decarboxylase (HDC−/−) gene, thus 
lacking histamine, were highly resistant to lethal infection by 
P. berghei ANKA and P. berghei NK65, associated with decreased 
brain-infiltrating T cells and expression of adhesion molecules. 
After treatment with antihistamine drugs, mice infected with 
P. berghei had prolonged survival compared to infected mice 
without antihistamine treatment (21).
Vascular endothelial growth factor (VEGF) is both neuropro-
tective and pro-inflammatory in the brain. VEGF was shown to 
accumulate intracellularly in P. falciparum-infected red blood 
cells in vitro, and inhibition of VEGF receptor (VEGFR)-2 signal-
ing reduced intraerythrocytic growth of P. falciparum (53). VEGF 
TABLe 1 | The function of mast cells (MCs) in Plasmodium spp., Leishmania spp., Trypanosoma spp., and Toxoplasma gondii infections.
Parasite MC/disease Animal model/patient sample Mechanism no involvement Reference
Plasmodium 
spp.
In the skin of 
patients or 
animals with 
Plasmodium 
infection
Patients with Plasmodium falciparum malaria Significantly increased MC degranulation was correlated with parasitemia 
and disease severity
Wilainam et al. (16)
Swiss mice exposed to Anopheles gambiae 
mosquitoes infected with Plasmodium berghei 
NK65
MCs were observed in the vicinity of sporozoites at 1 h after mosquito bite Choumet et al. (17)
In the brains 
of mice with 
Plasmodium 
infection
C57BL/6-WBB6F1-W/Wv (W/Wv) and wild-type 
WBB6F1+/+ (+/+) mice infected with P. berghei 
ANKA
+/+ mice had lower parasitemia and mortality, with higher tumor necrosis 
factor levels compared to W/Wv mice
Furuta et al. (18)
MC-deficient and basophil-depleted C57BL/6 
mice infected with P. berghei ANKA
MCs and basophils were not 
involved in the development of 
experimental cerebral malaria
Porcherie et al. (19)
H3R−/− mice infected with P. berghei ANKA The severity of cerebral malaria was correlated with the increased plasmatic 
levels of histamine in H3R−/− mice
Beghdadi et al. (20)
Histidine decarboxylase-deficient (HDC−/−) 
C57BL/6 mice infected with P. berghei
HDC−/− mice were highly resistant to P. berghei infection, with a drastic 
reduction of brain-infiltrating T cells and decreased expression of adhesion 
molecules
Beghdadi et al. (21)
Infected wild-type C57BL/6 mice showed prolonged survival after treatment 
with antihistamine drugs
In the 
intestines of 
animals with 
Plasmodium 
infection
Mice infected with Plasmodium yoelii Increased ileal mucosal MCs was positively correlated with elevated 
parasitemia and ileal interleukin (IL)-4 levels
Chau et al. (22)
Rhesus macaques infected with Plasmodium 
fragile
Ileal mastocytosis and increased plasma histamine levels were exhibited Potts et al. (23)
Antihistamine treatment of P. yoelii-infected CBA/J 
mice
MCs and histamine were involved in increased intestinal permeability during 
Plasmodium infection
Leishmania 
spp.
In the skin of 
patients and 
animals with 
Leishmania 
infection
Patients with cutaneous leishmaniasis caused by 
Leishmania braziliensis
There was a positive association between the disease duration and MCs 
count in the skin biopsy
Tuon et al. (24)
Susceptible (BALB/c) and resistant (C57BL/6 and 
CBA/T6T6) mice infected with Leishmania major
MC numbers were significantly increased in the upper dermis of BALB/c but 
not in those of C57BL/6 and CBA/T6T6 mice after L. major infection
Saha et al. (25)
MC-deficient KitW-sh/KitW-sh mice infected with L. 
major
Significantly enhanced lesion progression and lesional parasite burdens 
were observed, accompanied by significantly decreased levels of IFN-γ and 
IL-17A
Dudeck et al. (26)
Dogs infected with Leishmania infantum/chagasi Dermic inflammatory reaction with many degranulated MCs was observed Calabrese et al. (27)
Skin samples from dogs naturally infected with L. 
infantum
Increased number of MCs in the skin was correlated with clinical progression 
of canine visceral leishmaniasis
Menezes-Souza 
et al. (28)
MC-deficient KitW/KitW-v mice and normal Kit+/+ 
mice infected with L. major
Increased lesion sizes and lesional parasitic loads and reduced locally 
infiltrating cells were observed in KitW/KitW-v mice
Maurer et al. (29)
C57BL/6 or BALB/c mice infected with L. major MCs had no role on lesion size 
development, parasitic load, 
and immune cell phenotypes 
during murine cutaneous 
leishmaniasis
Paul et al. (30)
In visceral 
leishmaniasis
Dogs naturally infected with L. infantum Lower number of MCs was observed in the lamina propria of gastrointestinal 
tract of the infected dogs
Pinto et al. (31)
(Continued )
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Parasite MC/disease Animal model/patient sample Mechanism no involvement Reference
In ocular 
leishmaniasis
C57BL/10 and BALB/c mice, both susceptible 
to leishmaniasis, infected with Leishmania 
amazonensis by intravitreal injection and 
instillation, respectively
Many intact MCs were presented in the conjunctiva of both strains of mice 
at 30 days after infection, while degranulated MCs were observed in the 
conjunctiva of BALB/c mice at 60 days after infection
Calabrese et al. (32)
Trypanosoma 
spp.
In chagasic 
megacolon
Patients with Chagas disease caused by 
Trypanosoma cruzi
The number of tryptase-positive MCs was significantly increased in the 
lamina propria, muscle layer, or myenteric plexus region
Martins et al. (33)
A greater MC count and more fibrosis were found in the colon musculature 
with megacolon compared to that without megacolon
Pinheiro et al. (34)
Patients with megaesophagus had increased numbers of tryptase-positive 
MCs
Martins et al. (14)
Swiss mice infected with T. cruzi Y strain Significantly increased number of MCs was observed in the muscular layer 
of mice with chagasic megacolon
Campos et al. (35)
In Chagas 
heart disease
CBA mice infected with T. cruzi plus cromolyn 
treatment
Greater parasitemia, higher mortality, myocarditis, and cardiac damage were 
found in the infected mice treated with MC stabilizer
Meuser-Batista et al. 
(36)
Patients with chronic Chagas disease MC chymase density was associated with the intensity of myocardium 
fibrosis of chronic Chagas disease
Roldão et al. (37)
In 
Trypanosoma 
brucei 
infection
Rats infected with T. brucei The levels of MCs in the 
intestines of T. brucei-infected 
rats were similar to those of 
uninfected controls
Gould and Castro 
(38)
T. gondii In 
toxoplasmic 
encephalitis
A patient with meningoencephalitic toxoplasmosis Systemic cutaneous and gastrointestinal mastocytosis were observed Koeppel et al. (39)
In ocular 
T. gondii 
infection
Calomys callosus inoculated with T. gondii RH 
strain via the conjunctiva
Significantly increased MC number and MC activation were observed in the 
ocular tissues
Gil et al. (40)
In oral 
T. gondii 
infection
MC-deficient mice (W/Wv) and control +/+ orally 
infected with cysts of T. gondii ME49 strain
Rapid lethality of T. gondii infection and decreased serum IFN-γ levels were 
observed in the infected mice in the absence of MCs
Cruz et al. (41)
In 
intraperitoneal 
T. gondii 
infection
C. callosus infected with T. gondii RH strain The number of degranulated MCs was significantly higher than that of intact 
MCs, with a remarkable increase in the influx of neutrophils and Mφ toward 
the peritoneal cavity
Ferreira et al. (42)
MC-deficient KitW/KitW-v mice infected with T. 
gondii RH strain
The influx of Ly6G+ cells toward the peritoneal cavity was significantly 
reduced compared to control littermates
Del Rio et al. (43)
Kunming outbred mice infected with T. gondii RH 
strain
Significantly increased parasite burden, tissue inflammation, and Th1 
cytokine mRNA levels were detected in the livers and spleens of infected 
mice treated with an activator of MC release
Huang et al. (44)
Significantly decreased parasite burden and tissue inflammation, and 
significantly increased Th2 cytokine mRNA levels were detected in the livers 
and spleens of infected mice treated with an inhibitor of MC release
TABLe 1 | Continued
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and soluble VEGFR (sVEGFR)-2 are increased in CM patients 
compared to healthy adults (54). Plasma VEGF concentrations 
in Kenyan children with CM are associated with an increased 
risk of neurological sequelae (55). sVEGFR-1 may play a patho-
logical role during chronic placenta malaria and hypertension 
in first-time mothers (56). Both P. falciparum and Plasmodium 
vivax crude antigens induce VEGF release from the human MC 
line HMC-1 or the human basophilic cell line KU812 in vitro. 
Increased parasitemia of P. berghei ANKA was observed in 
anti-VEGF Ab-treated mice compared to non-treated mice (54). 
Furthermore, VEGF was shown to promote malaria-associated 
acute lung injury induced by P. berghei ANKA in mice (57). 
The pro-inflammatory cytokine interleukin (IL)-33 is strongly 
enhanced in infants (<5 years) with severe malaria from P. fal-
ciparum infection (58). IL-33 contributes to the stimulation and 
release of VEGF in human MCs (hMCs) (59). Conversely, IL-33 
prevents the development of ECM in C57BL/6 mice infected with 
P. berghei ANKA and reduces the production of inflammatory 
mediators IFN-γ, IL-12, and TNF-α (60).
MCs in the intestines of Animals with 
Plasmodium infection
In the gastrointestinal tract, MCs regulate vascular and epithelial 
permeability, ion secretion, angiogenesis, peristalsis, fibrosis, 
tissue repair, and innate and adaptive immunity (61). Increased 
numbers of mucosal MCs (MMCs) in the ileal villi and crypts 
and increased histamine levels in the ileum were detected in 
Plasmodium yoelii-infected mice. The increase in ileal MMCs 
was positively correlated with elevated parasitemia and IL-4 
mRNA levels in the same tissue. An additional study found that P. 
yoelii nigeriensis-infected mice develop an l-arginine deficiency, 
which is associated with intestinal mastocytosis, elevated levels 
of plasma histamine, and enhanced intestinal permeability (22). 
Plasmodium fragile-infected rhesus macaques have been shown 
to exhibit ileal mastocytosis and increased plasma histamine 
levels. Antihistamine treatment during P. yoelii infection results 
in decreased intestinal permeability in CBA/J mice, suggesting 
that MCs and histamine are involved in increased intestinal 
permeability during Plasmodium infection (23).
MCs in Leishmania spp. inFeCTiOn
Leishmaniasis is caused by several different species of Leishmania, 
and each infection has a different clinical outcome; human 
leishmaniasis is usually classified as cutaneous, mucocutaneous, 
or visceral. Leishmania parasites primarily live in Mφ (25), but 
Leishmania major and Leishmania infantum promastigotes can 
also bind to MC membranes and infect MCs (62).
MCs in the Skin of Patients and Animals 
with Leishmania infection
Cutaneous leishmaniasis is an important public health concern in 
many parts of the world, especially in Africa (63). MCs degranu-
late and release inflammatory mediators such as TNF-α after 
infection and recruit polymorphonuclear leukocytes (PMNs) to 
the site of infection (64). MCs can be important in cutaneous 
leishmaniasis and are involved in healing lesions. The MC count 
was higher in the skin biopsy of patients with cutaneous leish-
maniasis caused by Leishmania braziliensis with earlier healing 
after treatment, and there was a positive association between the 
disease duration and MC count (24).
After infection of Leishmania amazonensis in susceptible 
(C57BL/10 and CBA), relatively resistant (DBA/2), and resistant 
(C3H.He) mice, the primary lesions in footpads and draining 
lymph nodes showed a predominance of eosinophils and MCs 
in the initial phase of infection in all the infected mice (65). 
MC numbers increased significantly in the upper dermis in 
susceptible (BALB/c) but not in resistant (C57BL/6 and CBA/
T6T6) mice after L. major infection. However, the number of 
degranulating MCs was higher in CBA/T6T6 mice during early 
L. major infection. In addition, MC-derived cytokines, such as 
TNF-α, play a proparasitic role in a susceptible strain (BALB/c) 
of mice, but an antiparasitic role in resistant strains (C57BL/6 and 
CBA/T6T6) of mice, suggesting that the susceptible and resist-
ant mouse strains may have different modes of producing the 
antileishmanial immune response by differential regulation of 
MC function (25). After L. major inoculation, MC activation and 
parasite uptake by skin-resident Mφ occurred, followed by neu-
trophil and monocyte immigration and DC activation. Therefore, 
MC-dependent recruitment of Mφ, PMN, and DC to the skin 
is involved in controlling leishmaniasis (66). Furthermore, 
using MC-deficient KitW-sh/KitW-sh mice for infection with L. 
major promastigotes results in a worse disease outcome, e.g., 
significantly enhanced lesion progression and lesional parasite 
burdens, accompanied by significantly decreased levels of IFN-γ 
and IL-17A, but significantly increased IL-4 and IL-10, compared 
to wild-type mice, indicating that MCs play a crucial role against 
Leishmania parasites by promoting Th1 and Th17 responses 
in  vivo (26). L. infantum/chagasi-infected skins, from dogs of 
two different leishmaniasis endemic areas of Brazil, showed 
different skin infection patterns; however, dogs from both areas 
showed dermic inflammatory infiltrates composed of numerous 
degranulated MCs compared to normal skin, indicating that 
MCs modulate the immune response and participate in the 
host defense against Leishmania infection (27). Dogs naturally 
infected with L. infantum showed increased inflammatory infil-
trates in the skin of animals with severe forms of canine visceral 
leishmaniasis and a high parasite density. The increased number 
of Mφ and decreased number of lymphocytes, eosinophils, and 
MCs in the skin correlate with clinical progression of canine 
visceral leishmaniasis (28).
After susceptible BALB/c and resistant C57BL/6 mice were 
infected with L. major and pretreated with compound 48/80 (a 
MC activator), both BALB/c and C57BL/6 mice displayed smaller 
lesions in footpads compared to controls, indicating that MC 
degranulation contributes to susceptibility to L. major infection, 
and in the absence of granulated MCs, BALB/c and C57BL/6 mice 
had increased resistance to L. major infection. Although IL-4 
and MC degranulation are important to Leishmania-associated 
pathogenesis, the MC-mediated susceptibility seems to be inde-
pendent of IL-4 (67). MC-deficient C57BL/6-KitW/KitW-v mice 
and congenic wild-type Kit+/+ mice were infected with metacyclic 
promastigotes of L. major by intradermal injections, resulted in 
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significantly increased lesion sizes and lesional parasitic loads, 
and significantly reduced locally infiltrating cells in KitW/KitW-v 
mice. In addition, pronounced MC degranulation was observed 
in infected skin sites after intradermal injection of L. major in 
C57BL/6 mice, indicating that MCs provide protection against 
L. major infection (29). An in vitro study showed that stimula-
tion with Leishmania mexicana lipophosphoglycan led to a 
significant increase in degranulation in bone marrow-derived 
MCs (BMMCs) from BALB/c mice compared to BMMCs from 
C57BL/6 mice. Moreover, an in vivo study showed that after infec-
tion with L. mexicana, the number of MCs increased more rapidly 
and to a greater level, with significantly higher levels of parasites 
in the lesions of BALB/c mice compared to C57BL/6 mice. This 
indicates that MCs regulate the outcome of leishmaniasis and is 
dependent on the genetic background of the host (68). Conversely, 
a recent study showed that MC has no impact on the severity of 
cutaneous leishmaniasis in mice infected with L. major. By using 
Kit mutant mice with different genetic backgrounds, it was shown 
that MC deficiency did not affect lesion size development after L. 
major infection, suggesting that MCs are not involved in murine 
cutaneous Leishmania infections (30).
MCs in visceral Leishmaniasis
Visceral leishmaniasis is a serious public health problem that 
causes high morbidity and mortality (69). Analysis of Th1, Th2, 
and Th17 cytokine responses by cultured peripheral blood mono-
nuclear cells from patients who had developed kala-azar caused 
by Leishmania donovani, or who were protected against kala-azar, 
showed that IL-17 and IL-22 are the cytokines most strongly 
associated with protection against kala-azar (70). It has been 
reported that higher numbers of plasma cells, lymphocytes, and 
Mφ but lower number of MCs are present in the lamina propria of 
gastrointestinal tract of dogs naturally infected with L. infantum 
compared to non-infected controls, in all gastrointestinal tract 
segments (31). Thus, MCs may play different roles in visceral 
leishmaniasis and cutaneous leishmaniasis.
MCs in Mucocutaneous Leishmaniasis
Mucosal leishmaniasis is a chronic infection that affects the 
upper respiratory tract and/or the oral mucosa (71). Some 
patients diagnosed with mucosal leishmaniasis have oral lesions. 
Scraping cytology examination in patients with oral leishmania-
sis presented free Leishman-Donovan bodies or Mφ loaded with 
Leishman-Donovan bodies, acute and chronic inflammatory 
cells, histiocytes, multinucleated giant cells, MCs, and plasma 
cells (72).
MCs in Ocular Leishmaniasis
Ocular involvement is an unusual presentation of leishmaniasis 
and commonly limited to the eyelid skin (73). Both C57BL/10 
and BALB/c mice are susceptible to leishmaniasis, infected 
with L. amazonensis by intravitreal injection and instillation, 
respectively. Independent of the infective routes, C57BL/10 
mice infected intravitreally presented an intense inflammatory 
reaction in the epithelium of the eyelids, as well as the presence 
of many intact MCs in the conjunctiva of the eyes from 30 days 
postinfection (p.i.). On the other hand, BALB/c mice infected via 
the instillation route presented no lesions but an enhancement of 
intact MCs in the conjunctival region at 30 days p.i., and a discreet 
inflammatory infiltrate and degranulated MCs were observed in 
the conjunctival region at 60 days p.i. (32).
MC–TLRs interaction during Leishmania 
infection
To date, the regulatory effect of MCs on the pathogenesis of 
leishmaniasis is still unclear. The clearance of L. major strongly 
depends on TLRs (24). TLR9-deficient Mφ had reduced expres-
sions of CD40, IL-12, and TNF-α (74). MCs respond to TLR 
ligands by secreting cytokines, chemokines, and lipid mediators, 
and some studies have found that TLR ligands can also cause MC 
degranulation (75). The HMC-1 stimulated by promastigotes of 
L. braziliensis has a significantly greater release of histamine and 
IL-4 compared to control cells treated with medium (76). MCs 
release IL-3 and IL-4 to render Mφ susceptible to Leishmania 
infection in vitro (25).
MCs in Trypanosoma spp. inFeCTiOn
MCs in T. cruzi infection: Chagasic 
Megacolon
Megacolon is frequently observed in patients with Chagas disease 
caused by T. cruzi infection, which has been considered a conse-
quence of an inflammatory process, and inflammatory infiltrates 
are composed of lymphocytes, Mφ, natural killer cells, MCs, 
and eosinophils. Morphometric analyses in the lamina propria, 
muscle layer, or myenteric plexus region revealed that the num-
bers of both tryptase-immunoreactive MCs and eosinophils are 
significantly increased in patients with megacolon compared to 
uninfected individuals. MC and eosinophil activation, as well as 
their physical interaction, were observed by electron microscopy 
(33). T. cruzi-induced injury resulted in intramuscular fibrosis 
and increased thickness of the colon wall in patients with chagasic 
megacolon, and there was a greater MC count and more fibrosis 
in the circular colon musculature of chronic Chagas patients with 
megacolon compared to Chagas cases without megacolon (34). The 
density of MCs was significantly higher in the esophagus and 
large intestine in patients with AIDS plus Chagas disease reactiva-
tion compared to chronic chagasic patients without AIDS. This 
suggests that MCs may play a major role in esophageal and intes-
tinal inflammation during Chagas disease reactivation in HIV-
coinfected patients (77). MC-specific proteases (tryptase and 
chymase) influence the activation of inflammatory cells. Increased 
numbers of tryptase-immunoreactive MCs were found in the 
esophagus sections of T. cruzi-infected individuals with or with-
out megaesophagus. However, increased numbers of chymase- 
immunoreactive MCs were only found in the esophagus sections 
of infected individuals without megaesophagus compared to the 
control groups. Therefore, patients with megaesophagus had 
increased levels of tryptase-immunoreactive MCs (14).
One animal study showed that, after infection with the Y 
strain of T. cruzi, there were no significant differences in MC 
counts in the acute phase in Swiss mice. However, there was a 
significant increase in the number of MCs in the muscular layer 
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of chronically infected Swiss mice with chagasic megacolon com-
pared to non-infected control mice, accompanied by increased 
thickness of the colon wall, diffuse muscle cell hypertrophy, and 
increased collagen deposition (35), which may be associated with 
MC functions.
MCs in T. cruzi infection: Chagas Heart 
Disease
The density of MCs in the myocardium was shown to be signifi-
cantly higher in the chronic chagasic patients compared to control 
groups (77). The autopsied chagasic patient group showed higher 
MC chymase and MC tryptase densities and a higher percentage 
of collagen in the lingual muscles and myocardium compared 
to the non-chagasic patient group, and MC chymase level was 
associated with the intensity of myocardium fibrosis of chronic 
Chagas disease (37). Infiltrated T cells, Mφ, B cells, and MCs were 
all observed in the myocardium of patients with Chagas cardiopa-
thy, who died at an early mean age or at older ages. However, the 
numbers of T-lymphocytes and MCs were significantly higher in 
the cases who suffered early cardiac death (78).
One animal study showed that T. cruzi-infected CBA mice 
treated with cromolyn (a MC stabilizer) presented much greater 
parasitemia and IFN-γ levels, higher mortality, myocarditis, 
and cardiac damage, indicating that MCs control blood and 
tissue parasitemia, IFN-γ production, cardiac inflammation, and 
susceptibility to infection, suggesting that MCs are involved in 
resistance to this infection (36).
MCs in T. brucei infection
Trypanosoma brucei is a protozoan parasite that causes human 
African trypanosomiasis. Rats initially infected with T. brucei, 
followed by infection with Trichinella spiralis, showed that T. 
brucei infection does not significantly alter the number of MCs 
generated by T. spiralis infection, while the intestinal MC num-
bers in rats infected with only T. brucei were similar to those in 
uninfected rats (38).
MCs in T. gondii inFeCTiOn
MCs in Toxoplasmic encephalitis
Toxoplasmic encephalitis in patients with AIDS is a life-
threatening disease, mostly due to the reactivation of T. gondii 
cysts in the brain (79). It has been reported that a patient with 
meningoencephalitic toxoplasmosis was associated with systemic 
cutaneous and gastrointestinal mastocytosis, suggesting a pos-
sible relationship between MC proliferation and the parasitic 
infection (39).
MCs in Ocular T. gondii infection
Calomys callosus (Rodentia: Cricetidae) animals were inoculated 
intraperitoneally or via the conjunctiva with tachyzoites of the 
RH strain of T. gondii, resulting in the presence of the parasites 
and inflammatory cells and a significant increase in the number 
of MCs. Furthermore, MC activation in the ocular tissues was 
observed after infection, suggesting that MCs play an important 
role in the acute inflammatory response against T. gondii (40).
MCs in Oral T. gondii infection
Oral infection is the natural toxoplasmosis route, and the 
MC population is highly abundant in intestinal mucosa. In 
MC-deficient mice (W/Wv) and their control +/+ counterparts 
orally infected with cysts of the ME49 strain of T. gondii, rapid 
lethality and decreased IFN-γ levels were observed in the serum 
of infected mice in the absence of MCs. This demonstrated 
that MCs play a primordial role in resistance to oral infection 
with T. gondii, and MCs are required for survival of mice after 
oral infection with T. gondii (41). RBL-2H3 MCs infected with 
T. gondii type I (RH), II (PTG), or III (CTG or VEG) tachyzoites 
showed that acute T. gondii infection inhibits antigen-mediated 
MC degranulation, irrespective of the genotype of parasite used, 
and that tachyzoite attachment but not invasion is necessary 
for inhibiting degranulation. Ca2+ mobilization is a central and 
well-studied aspect of IgE/FcεRI-mediated signaling in MCs, and 
T. gondii infection has been shown to inhibit MC degranulation 
by suppressing antigen-mediated Ca2+ responses (80).
MCs in intraperitoneal T. gondii infection
After intraperitoneal infection with the RH strain of T. gondii, 
the number of non-degranulated MCs was significantly lower 
than that of degranulated cells in the peritoneal cavity, subman-
dibular and dorsal lymph nodes, and ileum in infected C. callosus 
compared to uninfected animals. After the MC degranulation, a 
remarkable increase in the influx of neutrophils and Mφ but a 
decrease in lymphocyte influx toward the peritoneal cavity of the 
infected animals were observed. MCs were observed interacting 
with other parasitized cells including Mφ, and extracellular para-
sites were destroyed during the interaction with MCs exhibiting 
degranulation. This suggests that MC is an important cell type 
during the inflammatory response against T. gondii (42). The use 
of MC-deficient KitW/KitW-v mice demonstrated that the influx 
of Ly6G+ cells toward the peritoneal cavity was significantly 
reduced compared to control littermates, indicating that MCs are 
an important chemokine source driving PMN recruitment to the 
peritoneal cavity during T. gondii infection (43). In both wild-type 
and serglycin-deficient mice, intraperitoneal infection with T. 
gondii resulted in highly increased extracellular levels of glycosa-
minoglycans, including hyaluronan and chondroitin sulfate A, 
suggesting that serglycin proteoglycan is dispensable for normal 
secretion and activity of MC proteases in response to T. gondii 
infection (81). A murine model showed that infection of T. gondii 
increased not only the number of MCs at the site of infection but 
also a noticeable degree of MC degranulation. Kunming outbred 
mice were infected intraperitoneally with the RH strain of T. 
gondii and treated by compound 48/80 or disodium cromoglycate 
(a MC stabilizer). The MC activator aggravated the pathology and 
increased the parasitic load, accompanied by upregulated mRNA 
levels of Th1 cytokines (IFN-γ, IL-12p40, or TNF-α) in the livers 
and spleens of T. gondii-infected mice. Conversely, the MC sta-
bilizer improved the pathology and decreased the parasitic load, 
accompanied by increased mRNA levels of Th2 cytokines (IL-4 
and IL-10) in the livers and spleens of mice infected with this 
parasite. In addition, significantly increased inflammatory foci 
of neutrophil infiltrates in different tissues occurred as a result 
of MC degranulation after the parasite infection (44). Thus, the 
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activation or inhibition of MCs is a key factor determining the 
fate of the infection and associated immunopathology.
MC–T. gondii interaction In Vitro
When T. gondii tachyzoites and MCs were incubated together, the 
tachyzoites adhered to the surface of the MCs, followed by MC 
degranulation. MC histamine and LTB4 release was significantly 
increased after incubation with the tachyzoites, which resulted in 
damage to the tachyzoites. MC-treated tachyzoites were found to 
be incapable of infection and replication in murine peritoneal Mφ. 
Therefore, LTB4 released by MCs and other inflammatory cells may 
be a key factor in the host defense against T. gondii (82). hMCs co-
cultured with T. gondii RH tachyzoites that were opsonized with 
IgG directed against the surface antigen 1 exhibited a polarized 
degranulation toward the invading parasites and resulted in the 
death of more than 70% of the parasites during the process. On 
the other hand, non-opsonized T. gondii rapidly infected MCs 
without triggering any detectable degranulation process, and only 
20% of the parasites died during the process. hMC treated with a 
chymase inhibitor did not affect parasite mortality, whereas hMC 
treated with a tryptase inhibitor significantly decreased the num-
ber of dead parasites in contact with degranulated MCs. Thus, 
IgG-opsonized T. gondii resulted in tryptase-dependent parasite 
death (83). TS-4 strain T. gondii infection significantly increased 
the expression of metalloproteinases (MMP)-2 and MMP-9 in 
P815 murine mastocytoma cells, and the invading parasites can 
elicit Erk1/2 phosphorylation, leading to NF-κB activation in the 
cytoplasm. This pathway for generating MMP-2 and MMP-9 is 
important in host defense mechanisms against T. gondii (84). The 
mediators of activated MCs play an important role in modulat-
ing acute inflammatory pathogenesis and parasite clearance in T. 
gondii infection (85).
COnCLUDinG ReMARKS
In this review, we have highlighted that MCs influence the 
outcome and immune response to Plasmodium spp., Leishmania 
spp., Trypanosoma spp., and T. gondii infections, and these 
protozoan parasites can all trigger MC activation, exhibiting 
an increase in the number of MCs and the degree of their 
degranulation, and have fundamentally diverse impacts on 
protozoan infections in different settings, i.e., protozoan para-
site infections can be controlled or may deteriorate through the 
release of different MC mediators, proteases, and cytokines, etc. 
In P. berghei-infected mice, MCs and MC-derived TNF play 
protective roles in murine malaria. In Leishmania infection, 
the MC count is positively associated with the disease dura-
tion of cutaneous leishmaniasis. During T. gondii infection, an 
increased MC number and greater MC activation are observed 
in infected animals. Furthermore, MCs are required for mouse 
survival after oral infection with T. gondii. However, MCs can 
also worsen the outcome of a protozoan infection under certain 
circumstances. For example, MC degranulation is significantly 
correlated with parasitemia and disease severity in human 
malaria; histamine-mediated signaling contributes to malaria 
pathogenesis. In T. cruzi infection, greater MC counts with 
more fibrosis are found in the colon musculature of chronic 
Chagas patients with megacolon or the myocardium of patients 
with Chagas cardiopathy. MC activation by MC stimulators can 
deteriorate the pathology and increase the parasitic load in acute 
T. gondii-infected mice. Moreover, some studies have shown 
that MCs have no impact on malaria pathogenesis caused by 
P. berghei ANKA and no effect on lesion size development by 
L. major infection in mouse models. In addition, the numbers of 
MCs in the intestines of T. brucei-infected rats are not significantly 
different compared to uninfected controls. Mediators from MCs 
play a key role in inflammation and in the pathogenesis of the 
protozoan parasitic diseases. Understanding the mechanisms by 
which MCs regulate pathogenesis during different protozoan 
parasite infections may potentially lead to the development 
of a new and unique therapeutic target for protozoan-related 
diseases. Therefore, further studies that evaluate the clinical 
importance of MC-protozoan interactions may lead to new 
therapeutic approaches for these protozoan parasitic diseases.
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